BiohackingHub Research Team
Editorial TeamThe BiohackingHub Research Team is the small, independent editorial team that researches, writes and edits every substance profile, protocol and article on this site. We read the primary literature, grade it on the Oxford CEBM scale and resolve every PubMed reference against NCBI before publishing. We are not physicians, and we do not review content as clinicians: when a page says a dose or a protocol is supported, it means the cited trials support it, not that it is a recommendation for you. Corrections are welcome and are logged with the date and what changed.
How the team works
- Independent editorial team — no clinicians on staff, and nothing we publish is medical advice
- Every PubMed reference is resolved through NCBI E-utilities before publication; references that do not match the claim are removed
- Evidence graded on the Oxford Centre for Evidence-Based Medicine scale, with the overall grade set by the weakest load-bearing claim
- Literature search is AI-assisted; drafting, editing, grading and source verification are done by the team
- No paid placements inside substance profiles or protocols; sponsored content is labelled and carries rel="sponsored"
Recent Reviewed Content
5-Amino-1MQ: Inhibiting NNMT to Prevent Fat Storage and Boost Cellular NAD+
Mar 1, 2026 · Oxford 4
9-Me-BC: Restoring Dopamine Receptors After Stimulant Burnout
Mar 1, 2026 · Oxford 4
Acarbose for Longevity: The ITP Drug That Extended Male Mouse Lifespan by 22% (2026)
Mar 26, 2026 · Oxford 2b
Acarbose + Rapamycin: The Advanced mTOR Sabbatical Protocol for Longevity
Mar 26, 2026 · Oxford 2b
Adaptogens Compared: Ashwagandha vs Rhodiola vs Holy Basil
Jul 1, 2026 · Oxford 1a
The Advanced Mitochondrial Stack: Mito-Peptides + Cofactors
Oct 3, 2026 · Oxford 5
Specialisations
Reviewed Substances
Member since
March 2026